Ultrasound Historical Financial Summary
Disclaimer
EGE HealthCare
This presentation contains forward-looking statements. These forward-looking statements might be identified by words, and variations of words, such as “will,” “expect,” “may,” “would," "could,"
"plan," "believe," "anticipate,” “intend,” “estimate,” “potential," "position," "forecast,” “target," "outlook," and similar expressions. These forward-looking statements may include, but are not
limited to, statements about the Company's expected financial performance and financial condition, including revenue growth, profit, cash flows, and earnings per share and the Company's 2022
outlook; taxes; the impacts of macroeconomic and market conditions and volatility on the Company's business operations, financial results and financial position and on the global supply chain
and world economy; the Company's strategy, innovation and investments; the Company's cost structure; the Company's funding and liquidity; and the impacts of the COVID-19 pandemic. These
forward-looking statements involve risks and uncertainties, many of which are beyond the Company's control. Factors that could cause our actual results to differ materially from those
described in the Company's forward-looking statements include, but are not limited to, operating in highly competitive markets; the actions or inactions of third parties with whom the Company
partners and the various collaboration, licensing, and other partnerships and alliances the Company has with third parties; demand for the Company's products, services, or solutions and factors
that affect that demand; management of the Company's supply chain and the Company's ability to cost-effectively secure the materials it needs to operate its business; disruptions in the
Company's operations; the global COVID-19 pandemic and its effects on the Company's business; maintenance and protection of the Company's intellectual property rights; the impact of
potential information technology, cybersecurity or data security breaches; compliance with the various legal, regulatory, tax, and other laws to which the Company is subject and related
changes, claims, or actions; environmental, social, and governance matters; the Company's ability to successfully complete strategic transactions; the Company's ability to operate effectively as
an independent, publicly-traded company and achieve the benefits the Company expects from its spin-off from General Electric Company; and the incurrence of substantial indebtedness in
connection with the spin-off and any related effect on the Company's business. Please also see the "Risk Factors" section of the Company's Form 10 filed with the U.S. Securities and Exchange
Commission and any updates or amendments it makes in future filings. There may be other factors not presently known to the Company or which it currently considers to be immaterial that
could cause the Company's actual results to differ materially from those projected in any forward-looking statements the Company makes. The Company does not undertake any obligation to
update or revise its forward-looking statements except as required by applicable law or regulation.
Use of Non-GAAP Financial Measures
In this presentation, we use some information derived from consolidated financial data but not presented in accordance with U.S. generally accepted accounting principles ("GAAP"). These are
considered "non-GAAP financial measures" under SEC rules. These non-GAAP financial measures supplement our disclosures and should not be considered an alternative to the comparable
GAAP measure. Please see the end of this presentation for GAAP to non-GAAP reconciliations including comparable GAAP measures, and please see our Form 10 for more information on the
reasons we use these non-GAAP financial measures.
Financial Comparisons
References to results increasing, decreasing, or remaining flat are in comparison to the same period in the prior fiscal year. Unless stated otherwise, quarterly and annual rates and ranges are
given on an organic basis.
Product Status
Not all products or features are available in all markets. The information presented here may involve technologies and concepts in development that are not products and may never become
products. For Technology in Development, the technologies or concepts are not being offered for sale, and are not cleared or approved by the U.S. FDA or any other global regulator for
commercial availability
© 2022, General Electric Company. Proprietary information. All rights reserved.
3View entire presentation